A Prospective, Multi-center, Open-label, Randomized, Two Period, Two Sequence, Crossover Study to Compare the Steady State Pharmacokinetics of Generic Tacrolimus (Sandoz) to Prograf in Stable Renal Transplant Patients
Phase of Trial: Phase IV
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 03 Jul 2012 Results published in the American Journal of Transplantation.
- 20 Jun 2012 Actual patient number is 71 according to ClinicalTrials.gov.
- 15 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.